Vandetanib

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Vandetanib are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Vandetanib?

The molecule Vandetanib presents a molecular formula of C22H24BrFN4O2 and its IUPAC name is N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine.

Vandetanib (marketed as Caprelsa by GlaxoSmithKline) is a small molecule inhibitor of the receptor tyrosine kinases VEGFR2 and VEGFR3. It is approved in the United States and the European Union for the treatment of symptomatic or progressive medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease..

MTC is a rare, aggressive form of thyroid cancer that accounts for approximately 3% of all thyroid cancers. The vast majority of MTC cases are caused by mutations in the RET proto-oncogene. These mutations lead to uncontrolled growth of the thyroid cells and can be passed down from generation to generation in families with a history of MTC..

Vandetanib works by binding to and inhibiting the activity of the VEGFR2 and VEGFR3 receptors. These receptors are important for the growth and spread of MTC cells. In clinical trials, vandetanib has been shown to slow the progression of MTC and improve symptoms in patients with advanced disease..

The most common side effects of vandetanib include diarrhea, hypertension, fatigue, and rash. Serious side effects include QT prolongation, which can lead to an irregular heartbeat and potentially fatal arrhythmias..

Vandetanib is a promising new treatment for patients with advanced MTC. It is well tolerated and has shown significant activity in clinical trials..

3D structure

Cartesian coordinates

Geometry of Vandetanib in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Vandetanib UHTHHESEBZOYNR-UHFFFAOYSA-N chemical compound 2D structure molecule svg
Vandetanib

 

Molecule descriptors

 
IUPAC nameN-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
InChI codeInChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)
InChI KeyUHTHHESEBZOYNR-UHFFFAOYSA-N
SMILESCOc1cc2/c(=N\c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • (4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(1-methyl-piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine
  • 2ivu
  • 338992-00-0
  • 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-yl)methoxyquinazoline
  • 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
  • 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE
  • 4-QUINAZOLINAMINE, N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYL-4- PIPERIDINYL)METHOXY)-
  • 4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-
  • 4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazoline
  • 443913-73-3
  • 443913-73-3 (free base)
  • 6-[(4R,5S,6S,7R)-4,7-dibenzyl-3-(5-carboxypentyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]hexanoic acid
  • 913V733
  • A25648
  • AB01273969-01
  • AB01273969-02
  • AB01273969_04
  • AC-5251
  • AMY599
  • AS-11067
  • AZD-6474
  • BCP01925
  • BCPP000023
  • BDBM21
  • BV164508
  • CCG-269495
  • CS-0130
  • Caprelsa
  • CH 331
  • CH-331
  • D06407
  • DB05294
  • DMPC Cyclic Urea 1
  • DSSTox_CID_26681
  • DSSTox_GSID_46681
  • DSSTox_RID_81816
  • EC-000.2359
  • EX-A422
  • F9995-0087
  • FT-0656736
  • GNF-PF-2188
  • GTPL5717
  • HMS3244K03
  • HMS3244K04
  • HMS3244L03
  • HMS3654E11
  • HMS3672C07
  • HSDB 8198
  • HY-10260
  • Kinome_3316
  • MFCD07772346
  • MLS006011672
  • N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine
  • N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
  • N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine
  • N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine
  • N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
  • NCGC00167513-01
  • NCGC00167513-02
  • NCGC00167513-03
  • NCGC00167513-04
  • NCGC00167513-09
  • NSC 744325
  • NSC 760766
  • NSC-744325
  • NSC-760766
  • NSC-800961
  • NSC744325
  • NSC760766
  • NSC800961
  • Q7914515
  • Quinazolin-4-amine, N-(4-bromo-2-fluorophenyl)-6-mthoxy-7-[(1-methyl-4-piperidinyl)methoxy]-
  • SB16919
  • SMR002530472
  • SR-00000000462
  • SR-00000000462-2
  • SW218092-2
  • SY027438
  • V-9402
  • Vandetanib
  • Vandetanib (JAN/USAN/INN)
  • Vandetanib (Zactima)
  • Vandetanib- Bio-X
  • Vandetanib;7-((4-aminocyclohexyl)methoxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine
  • Vandetinib
  • YO460OQ37K
  • ZD 6474
  • ZD-64
  • ZD-6474
  • ZD6
  • ZD6474
  • Zactima
  • cid_3081361
  • s1046
  • vandetanib (zd6474)

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC53683345
  • CAS-443913-73-3
  • UNII-YO460OQ37K
  • AKOS015902350
  • BRD-K77625799-001-01-0
  • DTXSID1046681
  • CHEMBL24828
  • CHEBI:49960
  • Tox21_112511
  • Tox21_112511_1
  • SCHEMBL9044
  • SCHEMBL21067679

Physico-Chemical properties

IUPAC nameN-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
Molecular formulaC22H24BrFN4O2
Molecular weight475.354
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity121.94
LogP4.4
Topological polar surface area62.7

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.